Among others, they identified HNRNPA1L2-SUGT1 chimeric RNA in CRC patients and, in addition, it resulted significantly more abundant in two of six colon cancer cell lines as compared to normal colon cell line [31]. This evidence concerns the gene HNRNPA1L2 and malignant colon neoplasm.